Cargando…
Phototest for neurocognitive screening in multiple sclerosis
Multiple Sclerosis (MS) is one of the most common neurological disorders. Cognitive dysfunction is considered a clinical marker of MS, where approximately half of patients with MS have cognitive impairment. OBJECTIVE: The Phototest (PT) is a brief cognitive test with high diagnostic sensitivity, acc...
Autores principales: | Pinto, Joana, Lopes, Emanuela, Gonçalves, Gerly, Silva, Ângela, Carnero-Pardo, Peixoto, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação de Neurologia Cognitiva e do Comportamento
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674908/ https://www.ncbi.nlm.nih.gov/pubmed/29213425 http://dx.doi.org/10.1590/S1980-57642016DN10100003 |
Ejemplares similares
-
Effectiveness and costs of phototest in dementia and cognitive impairment screening
por: Carnero-Pardo, Cristobal, et al.
Publicado: (2011) -
A systematic review and meta-analysis of the diagnostic accuracy of
the Phototest for cognitive impairment and dementia
por: Carnero-Pardo, Cristóbal, et al.
Publicado: (2014) -
Clinical utility of Phototest via teleneuropsychology in Chilean
rural older adults
por: Caldichoury, Nicole, et al.
Publicado: (2022) -
Spectrophotometric Measurement of Minimal Erythema Dose Sites after Narrowband Ultraviolet B Phototesting: Clinical Implication of Spetrophotometric Values in Phototherapy
por: Jeon, Su-Young, et al.
Publicado: (2014) -
Ultraviolet A phototest positivity is associated with higher free erythrocyte protoporphyrin IX concentration and lower transferrin saturation values in erythropoietic protoporphyria
por: Genovese, Giovanni, et al.
Publicado: (2021)